The case of Norplant as an example of media coverage over the life of a new health technology
BACKGROUND: The contraceptive implant Norplant (levonorgestrel) had a fairly short life in the UK. This made it a convenient subject for a case study of how media coverage alters over time. We set out to produce a critical description of national newspaper coverage of Norplant over the course of its use in the UK.
METHODS: We searched newspaper databases and press-clippings files for articles about Norplant printed between 1992 and 1996. For those that met our inclusion criteria, we extracted bibliographical data, made a standardised judgment about the "slant" of the article towards Norplant, and used qualitative techniques to analyse the content of the articles.
FINDINGS: 101 national newspaper articles were included in the study. Norplant attracted media coverage over the course of its career, but the slant of articles shifted dramatically over time from a favourable to a negative presentation. This reflected the use of different story types over the course of time. Early reports presented Norplant very positively as either a clear improvement on existing contraceptive methods or a valuable addition to the range. Any disadvantages were down-played. The positive image of Norplant was reinforced immediately after its official launch by reports that it was in great demand but women might be denied access to it. Less than a year later, however, newspaper reports about Norplant were dominated by the stories of individual women who had had bad experiences with the product.
INTERPRETATION: Three main reporting themes were seen. At first, Norplant was presented as a positive new development, and one that might be denied to people. In later coverage it became a flawed and damaging product. These themes recur in media reporting of health technologies, and the fact that they occur at different stages in a product's career means that a balanced assessment of the technology is not usually feasible from media reporting at any one time. An appreciation of the forms and implications of these reporting frameworks could help health-care providers and users to appraise media reports more critically.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2000 |
|---|---|
| Erschienen: |
2000 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:355 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 355(2000), 9215 vom: 06. Mai, Seite 1633-6 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Entwistle, V A [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 07.06.2000 Date Revised 24.11.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM107467933 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM107467933 | ||
| 003 | DE-627 | ||
| 005 | 20231222143113.0 | ||
| 007 | tu | ||
| 008 | 231222s2000 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0359.xml |
| 035 | |a (DE-627)NLM107467933 | ||
| 035 | |a (NLM)10821380 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Entwistle, V A |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The case of Norplant as an example of media coverage over the life of a new health technology |
| 264 | 1 | |c 2000 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 07.06.2000 | ||
| 500 | |a Date Revised 24.11.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: The contraceptive implant Norplant (levonorgestrel) had a fairly short life in the UK. This made it a convenient subject for a case study of how media coverage alters over time. We set out to produce a critical description of national newspaper coverage of Norplant over the course of its use in the UK | ||
| 520 | |a METHODS: We searched newspaper databases and press-clippings files for articles about Norplant printed between 1992 and 1996. For those that met our inclusion criteria, we extracted bibliographical data, made a standardised judgment about the "slant" of the article towards Norplant, and used qualitative techniques to analyse the content of the articles | ||
| 520 | |a FINDINGS: 101 national newspaper articles were included in the study. Norplant attracted media coverage over the course of its career, but the slant of articles shifted dramatically over time from a favourable to a negative presentation. This reflected the use of different story types over the course of time. Early reports presented Norplant very positively as either a clear improvement on existing contraceptive methods or a valuable addition to the range. Any disadvantages were down-played. The positive image of Norplant was reinforced immediately after its official launch by reports that it was in great demand but women might be denied access to it. Less than a year later, however, newspaper reports about Norplant were dominated by the stories of individual women who had had bad experiences with the product | ||
| 520 | |a INTERPRETATION: Three main reporting themes were seen. At first, Norplant was presented as a positive new development, and one that might be denied to people. In later coverage it became a flawed and damaging product. These themes recur in media reporting of health technologies, and the fact that they occur at different stages in a product's career means that a balanced assessment of the technology is not usually feasible from media reporting at any one time. An appreciation of the forms and implications of these reporting frameworks could help health-care providers and users to appraise media reports more critically | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Communication | |
| 650 | 4 | |a Contraception | |
| 650 | 4 | |a Contraceptive Agents | |
| 650 | 4 | |a Contraceptive Agents, Female | |
| 650 | 4 | |a Contraceptive Agents, Progestin | |
| 650 | 4 | |a Contraceptive Implants | |
| 650 | 4 | |a Contraceptive Methods | |
| 650 | 4 | |a Developed Countries | |
| 650 | 4 | |a Europe | |
| 650 | 4 | |a Family Planning | |
| 650 | 4 | |a Levonorgestrel | |
| 650 | 4 | |a Mass Media | |
| 650 | 4 | |a Newspapers | |
| 650 | 4 | |a Northern Europe | |
| 650 | 4 | |a Printed Media | |
| 650 | 4 | |a Research Report | |
| 650 | 4 | |a United Kingdom | |
| 650 | 7 | |a Contraceptive Agents, Female |2 NLM | |
| 650 | 7 | |a Levonorgestrel |2 NLM | |
| 650 | 7 | |a 5W7SIA7YZW |2 NLM | |
| 700 | 1 | |a Watt, I S |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 355(2000), 9215 vom: 06. Mai, Seite 1633-6 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:355 |g year:2000 |g number:9215 |g day:06 |g month:05 |g pages:1633-6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 355 |j 2000 |e 9215 |b 06 |c 05 |h 1633-6 | ||